Cancers, Vol. 15, Pages 1703: Classification of Chondrosarcoma: From Characteristic to Challenging Imaging Findings
Lee
Chondrosarcomas can be classified into various forms according to the presence or absence of a precursor lesion, location, and histological subtype. The new 2020 World Health Organization (WHO) Classification of Tumors of Soft Tissue and Bone classifies chondrogenic bone tumors as benign, intermediate (locally aggressive), or malignant, and separates atypical cartilaginous tumors (ACTs) and chondrosarcoma grade 1 (CS1) as intermediate and malignant tumors. respectively. Furthermore, the classification categorizes chondrosarcomas (including ACT) into eight subtypes: central conventional (grade 1 vs. 2–...
Source: Cancers - March 10, 2023 Category: Cancer & Oncology Authors: Jun-Ho Kim Seul Ki Lee Tags: Review Source Type: research
Whole lung radiotherapy to treat metastatic Extraskeletal Myxoid Chondrosarcomas
(Source: Clinical Oncology)
Source: Clinical Oncology - March 9, 2023 Category: Radiology Authors: Shawn David Ponniah Ellis, Charles Hamilton, Bass Hassan, Sarah Pratapa, Sally Trent Tags: Letter Source Type: research
Malignant Phyllodes Tumor with Heterologous Osteosarcomatous and Rhabdomyosarcomatous Elements: A Case Report and Literature Review
Ann Clin Lab Sci. 2023 Jan;53(1):159-163.ABSTRACTPhyllodes tumor (PT) is an uncommon fibroepithelial lesion of the breast. PT can be classified as benign, borderline, and malignant based on semi-quantitative assessment of stromal hypercellularity and overgrowth, cytologic atypia, mitotic activity, tumor border, and presence of malignant heterologous elements. PT is considered malignant by default, if malignant heterologous elements are encountered. The heterologous elements include liposarcoma, angiosarcoma, osteosarcoma, chondrosarcoma, and rhabdomyosarcoma. Malignant PT (MPT) with rhabdomyosarcomatous component is extrem...
Source: Annals of Clinical and Laboratory Science - March 8, 2023 Category: Laboratory Medicine Authors: Haval Ali Ali M Moosvi Y Helen Zhang Hongxia Sun Source Type: research
Malignant Phyllodes Tumor with Heterologous Osteosarcomatous and Rhabdomyosarcomatous Elements: A Case Report and Literature Review
Ann Clin Lab Sci. 2023 Jan;53(1):159-163.ABSTRACTPhyllodes tumor (PT) is an uncommon fibroepithelial lesion of the breast. PT can be classified as benign, borderline, and malignant based on semi-quantitative assessment of stromal hypercellularity and overgrowth, cytologic atypia, mitotic activity, tumor border, and presence of malignant heterologous elements. PT is considered malignant by default, if malignant heterologous elements are encountered. The heterologous elements include liposarcoma, angiosarcoma, osteosarcoma, chondrosarcoma, and rhabdomyosarcoma. Malignant PT (MPT) with rhabdomyosarcomatous component is extrem...
Source: Annals of Clinical and Laboratory Science - March 8, 2023 Category: Laboratory Medicine Authors: Haval Ali Ali M Moosvi Y Helen Zhang Hongxia Sun Source Type: research
Malignant Phyllodes Tumor with Heterologous Osteosarcomatous and Rhabdomyosarcomatous Elements: A Case Report and Literature Review
Ann Clin Lab Sci. 2023 Jan;53(1):159-163.ABSTRACTPhyllodes tumor (PT) is an uncommon fibroepithelial lesion of the breast. PT can be classified as benign, borderline, and malignant based on semi-quantitative assessment of stromal hypercellularity and overgrowth, cytologic atypia, mitotic activity, tumor border, and presence of malignant heterologous elements. PT is considered malignant by default, if malignant heterologous elements are encountered. The heterologous elements include liposarcoma, angiosarcoma, osteosarcoma, chondrosarcoma, and rhabdomyosarcoma. Malignant PT (MPT) with rhabdomyosarcomatous component is extrem...
Source: Annals of Clinical and Laboratory Science - March 8, 2023 Category: Laboratory Medicine Authors: Haval Ali Ali M Moosvi Y Helen Zhang Hongxia Sun Source Type: research
Malignant Phyllodes Tumor with Heterologous Osteosarcomatous and Rhabdomyosarcomatous Elements: A Case Report and Literature Review
Ann Clin Lab Sci. 2023 Jan;53(1):159-163.ABSTRACTPhyllodes tumor (PT) is an uncommon fibroepithelial lesion of the breast. PT can be classified as benign, borderline, and malignant based on semi-quantitative assessment of stromal hypercellularity and overgrowth, cytologic atypia, mitotic activity, tumor border, and presence of malignant heterologous elements. PT is considered malignant by default, if malignant heterologous elements are encountered. The heterologous elements include liposarcoma, angiosarcoma, osteosarcoma, chondrosarcoma, and rhabdomyosarcoma. Malignant PT (MPT) with rhabdomyosarcomatous component is extrem...
Source: Annals of Clinical and Laboratory Science - March 8, 2023 Category: Laboratory Medicine Authors: Haval Ali Ali M Moosvi Y Helen Zhang Hongxia Sun Source Type: research
Malignant Phyllodes Tumor with Heterologous Osteosarcomatous and Rhabdomyosarcomatous Elements: A Case Report and Literature Review
Ann Clin Lab Sci. 2023 Jan;53(1):159-163.ABSTRACTPhyllodes tumor (PT) is an uncommon fibroepithelial lesion of the breast. PT can be classified as benign, borderline, and malignant based on semi-quantitative assessment of stromal hypercellularity and overgrowth, cytologic atypia, mitotic activity, tumor border, and presence of malignant heterologous elements. PT is considered malignant by default, if malignant heterologous elements are encountered. The heterologous elements include liposarcoma, angiosarcoma, osteosarcoma, chondrosarcoma, and rhabdomyosarcoma. Malignant PT (MPT) with rhabdomyosarcomatous component is extrem...
Source: Annals of Clinical and Laboratory Science - March 8, 2023 Category: Laboratory Medicine Authors: Haval Ali Ali M Moosvi Y Helen Zhang Hongxia Sun Source Type: research
Malignant Phyllodes Tumor with Heterologous Osteosarcomatous and Rhabdomyosarcomatous Elements: A Case Report and Literature Review
Ann Clin Lab Sci. 2023 Jan;53(1):159-163.ABSTRACTPhyllodes tumor (PT) is an uncommon fibroepithelial lesion of the breast. PT can be classified as benign, borderline, and malignant based on semi-quantitative assessment of stromal hypercellularity and overgrowth, cytologic atypia, mitotic activity, tumor border, and presence of malignant heterologous elements. PT is considered malignant by default, if malignant heterologous elements are encountered. The heterologous elements include liposarcoma, angiosarcoma, osteosarcoma, chondrosarcoma, and rhabdomyosarcoma. Malignant PT (MPT) with rhabdomyosarcomatous component is extrem...
Source: Annals of Clinical and Laboratory Science - March 8, 2023 Category: Laboratory Medicine Authors: Haval Ali Ali M Moosvi Y Helen Zhang Hongxia Sun Source Type: research
Malignant Phyllodes Tumor with Heterologous Osteosarcomatous and Rhabdomyosarcomatous Elements: A Case Report and Literature Review
Ann Clin Lab Sci. 2023 Jan;53(1):159-163.ABSTRACTPhyllodes tumor (PT) is an uncommon fibroepithelial lesion of the breast. PT can be classified as benign, borderline, and malignant based on semi-quantitative assessment of stromal hypercellularity and overgrowth, cytologic atypia, mitotic activity, tumor border, and presence of malignant heterologous elements. PT is considered malignant by default, if malignant heterologous elements are encountered. The heterologous elements include liposarcoma, angiosarcoma, osteosarcoma, chondrosarcoma, and rhabdomyosarcoma. Malignant PT (MPT) with rhabdomyosarcomatous component is extrem...
Source: Annals of Clinical and Laboratory Science - March 8, 2023 Category: Laboratory Medicine Authors: Haval Ali Ali M Moosvi Y Helen Zhang Hongxia Sun Source Type: research
Malignant Phyllodes Tumor with Heterologous Osteosarcomatous and Rhabdomyosarcomatous Elements: A Case Report and Literature Review
Ann Clin Lab Sci. 2023 Jan;53(1):159-163.ABSTRACTPhyllodes tumor (PT) is an uncommon fibroepithelial lesion of the breast. PT can be classified as benign, borderline, and malignant based on semi-quantitative assessment of stromal hypercellularity and overgrowth, cytologic atypia, mitotic activity, tumor border, and presence of malignant heterologous elements. PT is considered malignant by default, if malignant heterologous elements are encountered. The heterologous elements include liposarcoma, angiosarcoma, osteosarcoma, chondrosarcoma, and rhabdomyosarcoma. Malignant PT (MPT) with rhabdomyosarcomatous component is extrem...
Source: Annals of Clinical and Laboratory Science - March 8, 2023 Category: Laboratory Medicine Authors: Haval Ali Ali M Moosvi Y Helen Zhang Hongxia Sun Source Type: research
Malignant Phyllodes Tumor with Heterologous Osteosarcomatous and Rhabdomyosarcomatous Elements: A Case Report and Literature Review
Ann Clin Lab Sci. 2023 Jan;53(1):159-163.ABSTRACTPhyllodes tumor (PT) is an uncommon fibroepithelial lesion of the breast. PT can be classified as benign, borderline, and malignant based on semi-quantitative assessment of stromal hypercellularity and overgrowth, cytologic atypia, mitotic activity, tumor border, and presence of malignant heterologous elements. PT is considered malignant by default, if malignant heterologous elements are encountered. The heterologous elements include liposarcoma, angiosarcoma, osteosarcoma, chondrosarcoma, and rhabdomyosarcoma. Malignant PT (MPT) with rhabdomyosarcomatous component is extrem...
Source: Annals of Clinical and Laboratory Science - March 8, 2023 Category: Laboratory Medicine Authors: Haval Ali Ali M Moosvi Y Helen Zhang Hongxia Sun Source Type: research
Malignant Phyllodes Tumor with Heterologous Osteosarcomatous and Rhabdomyosarcomatous Elements: A Case Report and Literature Review
Ann Clin Lab Sci. 2023 Jan;53(1):159-163.ABSTRACTPhyllodes tumor (PT) is an uncommon fibroepithelial lesion of the breast. PT can be classified as benign, borderline, and malignant based on semi-quantitative assessment of stromal hypercellularity and overgrowth, cytologic atypia, mitotic activity, tumor border, and presence of malignant heterologous elements. PT is considered malignant by default, if malignant heterologous elements are encountered. The heterologous elements include liposarcoma, angiosarcoma, osteosarcoma, chondrosarcoma, and rhabdomyosarcoma. Malignant PT (MPT) with rhabdomyosarcomatous component is extrem...
Source: Annals of Clinical and Laboratory Science - March 8, 2023 Category: Laboratory Medicine Authors: Haval Ali Ali M Moosvi Y Helen Zhang Hongxia Sun Source Type: research
Malignant Phyllodes Tumor with Heterologous Osteosarcomatous and Rhabdomyosarcomatous Elements: A Case Report and Literature Review
Ann Clin Lab Sci. 2023 Jan;53(1):159-163.ABSTRACTPhyllodes tumor (PT) is an uncommon fibroepithelial lesion of the breast. PT can be classified as benign, borderline, and malignant based on semi-quantitative assessment of stromal hypercellularity and overgrowth, cytologic atypia, mitotic activity, tumor border, and presence of malignant heterologous elements. PT is considered malignant by default, if malignant heterologous elements are encountered. The heterologous elements include liposarcoma, angiosarcoma, osteosarcoma, chondrosarcoma, and rhabdomyosarcoma. Malignant PT (MPT) with rhabdomyosarcomatous component is extrem...
Source: Annals of Clinical and Laboratory Science - March 8, 2023 Category: Laboratory Medicine Authors: Haval Ali Ali M Moosvi Y Helen Zhang Hongxia Sun Source Type: research
Cancers, Vol. 15, Pages 1660: Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone: The PROSPER Study Rationale and Design
Anna C. Harrell
Matthew T. Houdek
Laura A. Vallow
Peter S. Rose
Michael G. Haddock
Jonathan B. Ashman
Krista A. Goulding
Steven Attia
Sunil Krishnan
Anita Mahajan
Robert L. Foote
Nadia N. Laack
Sameer R. Keole
Chris J. Beltran
Eric M. Welch
Mohammed Karim
Safia K. Ahmed
Surgical treatment of pelvic sarcoma involving the bone is the standard of care but is associated with several sequelae and reduced functional quality of life (QOL). Treatment with photon and proton radiotherapy is associated with relapse. Carbon ion radiotherapy (CIRT) may reduce both relapse rates and treatment sequelae...
Source: Cancers - March 8, 2023 Category: Cancer & Oncology Authors: Bradford S. Hoppe Ivy A. Petersen Benjamin K. Wilke Todd A. DeWees Reiko Imai Eugen B. Hug Maria Rosaria Fiore J ürgen Debus Piero Fossati Shigeru Yamada Ester Orlandi Qing Zhang Cihang Bao Katharina Seidensaal Byron C. May Anna C. Harrell Matthew T. Hou Tags: Study Protocol Source Type: research
